Metabolic Precision Medicines: Curing POMC Deficiency.

Titel:: Metabolic Precision Medicines: Curing POMC Deficiency.
Dokumenttyp:: Journal Article; Editorial Material
Autor(en):: Müller, Timo D; Tschöp, Matthias H; O'Rahilly, Stephen
Abstract:: Pro-opiomelanocortin deficiency is a rare cause of severe intractable obesity. Two patients have experienced dramatic weight loss in response to setmelanotide, a melanocortin-4 receptor activator. The drug has potential in broader populations, but caution is warranted as it may act at other melanocortin receptors.
Zeitschriftentitel:: Cell Metab
Jahr:: 2016
Band / Volume:: 24
Heft / Issue:: 2
Seitenangaben Beitrag:: 194-5
Volltext / DOI:: doi:10.1016/j.cmet.2016.07.006
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/27452145
Print-ISSN:: 1550-4131
TUM Einrichtung:: Lehrstuhl für Stoffwechselerkrankungen (Prof. Tschöp)
BibTeX

Vorkommen: